# Comparison of the Efficacy and Safety of Two Insulin Intensification Strategies

> **NCT01175824** · PHASE4 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 478 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Insulin Lispro Low Mixture (LM)
- **DRUG:** Insulin Glargine
- **DRUG:** Prandial Insulin Lispro

## Key facts

- **NCT ID:** NCT01175824
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 478 (ACTUAL)
- **Last updated:** 2014-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01175824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01175824, "Comparison of the Efficacy and Safety of Two Insulin Intensification Strategies". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01175824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*